BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1709 related articles for article (PubMed ID: 33563332)

  • 1. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.
    Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM
    Sci Rep; 2022 May; 12(1):7784. PubMed ID: 35546164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice.
    Ou Z; Kong X; Sun X; He X; Zhang L; Gong Z; Huang J; Xu B; Long D; Li J; Li Q; Xu L; Xuan A
    Brain Behav Immun; 2018 Mar; 69():351-363. PubMed ID: 29253574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MTK; Vickers JC
    J Neurotrauma; 2019 Jun; 36(11):1876-1889. PubMed ID: 30623730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
    Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
    Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)-[
    Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
    Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies.
    Li C; Guo XD; Lei M; Wu JY; Jin JZ; Shi XF; Zhu ZY; Rukachaisirikul V; Hu LH; Wen TQ; Shen X
    Acta Pharmacol Sin; 2017 Jan; 38(1):9-28. PubMed ID: 27694908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
    Clayton K; Delpech JC; Herron S; Iwahara N; Ericsson M; Saito T; Saido TC; Ikezu S; Ikezu T
    Mol Neurodegener; 2021 Mar; 16(1):18. PubMed ID: 33752701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.